Feb 12, 2026 04:40PM
Jan 26, 2026 05:33AM
Jan 8, 2026 04:13AM
Dec 12, 2025 03:00PM
Dec 12, 2025 09:19AM
Dec 12, 2025 07:12AM
Dec 12, 2025 06:43AM Rezolute (RZLT) PT Lowered to $5 at H.C. Wainwright
Dec 11, 2025 12:27PM
Dec 11, 2025 11:37AM
Dec 11, 2025 10:22AM
Nov 12, 2025 07:32AM
Nov 6, 2025 06:24PM
Nov 6, 2025 06:24PM
Oct 29, 2025 04:26AM Rezolute (RZLT) PT Raised to $17 at Citizens After Phase 3 sunRIZE Results
Sep 18, 2025 05:27AM
Sep 18, 2025 04:12AM
Sep 3, 2025 06:49AM
Aug 20, 2025 06:14AM
Jul 24, 2025 08:49AM
Jul 17, 2025 05:06PM
May 28, 2025 02:27PM BTIG Reiterates Buy Rating on Rezolute (rzlt)
May 28, 2025 08:02AM
May 14, 2025 04:55PM
May 5, 2025 08:02AM
Apr 23, 2025 08:05AM
Apr 23, 2025 08:04AM
Mar 26, 2025 07:31AM
Feb 13, 2025 04:14AM Rezolute (RZLT) PT Raised to $9 at JMP Securities
Feb 12, 2025 05:43PM
Feb 5, 2025 06:40AM
Feb 4, 2025 08:00AM
Jan 7, 2025 08:02AM
Dec 4, 2024 06:01AM
Dec 3, 2024 08:00AM
Nov 8, 2024 07:16AM Rezolute, Inc. (RZLT) Tops Q1 EPS by 9c
Sep 27, 2024 06:50AM
Sep 20, 2024 11:55AM
Sep 20, 2024 05:22AM
Sep 10, 2024 06:43AM
Sep 9, 2024 11:58AM
Sep 9, 2024 08:38AM
Sep 9, 2024 07:30AM Rezolute Inc. (RZLT): FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study
Aug 5, 2024 05:02PM
Aug 5, 2024 07:30AM
Jul 17, 2024 06:07AM
Jun 27, 2024 08:02AM
Jun 13, 2024 04:01PM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All